HighTower Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

HighTower Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$243K	Sell	16,948 -9,203	-35%	-$137K	﹤0.01%	3333
2025 Q4	$394K	Buy	+26,151	New	+$393K	﹤0.01%	2820
2024 Q1	–	Sell	-69,907	Closed	-$1.02M	–	3645
2023 Q4	$1.02M	Buy	+69,907	New	+$976K	﹤0.01%	1829
2023 Q1	–	Sell	-74,681	Closed	-$1.16M	–	3425
2022 Q4	$1.16M	Buy	+74,681	New	+$1.16M	﹤0.01%	1596
2021 Q4	–	Sell	-14,278	Closed	-$385K	–	3307
2021 Q3	$385K	Buy	14,278 +1,880	+15%	+$53.8K	﹤0.01%	2249
2021 Q2	$358K	Buy	+12,398	New	+$343K	﹤0.01%	2248

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

HighTower Advisors's BMEZ Position: Q1 2026 in Review

HighTower Advisors reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 35% in Q1 2026, selling an estimated $137K and leaving 16,948 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #3333.

HighTower Advisors first reported a position in BMEZ in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.16M in Q4 2022. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

HighTower Advisors held 16,948 shares of BlackRock Health Sciences Trust II worth $243K as of Q1 2026.
HighTower Advisors sold 9,203 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $137K.
BlackRock Health Sciences Trust II made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3333 holding.
HighTower Advisors first reported a position in BlackRock Health Sciences Trust II in Q2 2021 and has held it in 6 quarters since.
HighTower Advisors's BlackRock Health Sciences Trust II position peaked at $1.16M in Q4 2022.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.